[Differentiation of the specific and nonspecific effects in the carcinostatic action of hydroxythiamine].
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001769:Blood / Q000378:metabolism; D001835:Body Weight / Q000187:drug effects; D004032:Diet; D007274:Injections, Intraperitoneal; D008099:Liver / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009132:Muscles / Q000378:metabolism; D009368:Neoplasm Transplantation; D011743:Pyrimidines / Q000494:pharmacology; D012513:Sarcoma, Experimental / Q000188:drug therapy / Q000201:enzymology; D013154:Spleen / Q000378:metabolism; D013831:Thiamine / Q000008:administration & dosage / Q000037:antagonists & inhibitors* / Q000378:metabolism; D013844:Thiazoles / Q000008:administration & dosage / Q000494:pharmacology*; D013997:Time Factors; D014174:Transketolase / Q000378:metabolism; D014815:Vitamins / Q000008:administration & dosage
D000970:Antineoplastic Agents; D011743:Pyrimidines; D013844:Thiazoles; D014815:Vitamins; D014174:Transketolase; D013831:Thiamine
Differentsiatsiia spetsificheskikh i nespetsificheskikh éffektov v kantserostaticheskom deĭstvii oksitiamina